SCHEMBL1817603

SCHEMBL1817603

CN(C)c1ccc(S(=O)(=O)N2CCOc3ccc(-c4csc(C#N)c4)cc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.42
▸ NPC1 O15118 1/20 0.40
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ PKM P14618 1/20 0.36
▸ PKLR P30613 1/20 0.36
▸ PDE3B Q13370 4/20 0.36
▸ PDE3A Q14432 4/20 0.36
▸ NR1H3 Q13133 2/20 0.36
▸ RORC P51449 1/20 0.36
▸ NR1H2 P55055 1/20 0.36
▸ CPT1A P50416 1/20 0.35
▸ CPT1B Q92523 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ NR3C1 P04150 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ NR3C2 P08235 1/20 0.34
▸ AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1816941 0.89 CYP2C9 (0.53) CYP2C9NPC1MEN1KMT2APKM
SCHEMBL1819206 0.87 PKM (0.42) CYP2C9NPC1MEN1KMT2APKM
SCHEMBL1817593 0.87 NR1H3 (0.46) CYP2C9NPC1MEN1KMT2APKM
SCHEMBL1819614 0.87 NPC1 (0.57) CYP2C9NPC1MEN1KMT2APKM
SCHEMBL1817317 0.87 CYP2C9 (0.44) CYP2C9NPC1MEN1KMT2APKM
SCHEMBL1816305 0.87 CYP2C9 (0.37) CYP2C9NPC1MEN1KMT2APDE3B
SCHEMBL1821637 0.86 PKM (0.48) CYP2C9NPC1MEN1KMT2APKM
SCHEMBL1818343 0.86 PKM (0.48) CYP2C9NPC1MEN1KMT2APKM
SCHEMBL1820750 0.85 CYP2C9 (0.42) CYP2C9NPC1MEN1KMT2APKM
SCHEMBL1818994 0.84 CYP2C9 (0.42) CYP2C9NPC1MEN1KMT2APDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback